Showing results (451-460 of 466) with videos related to

Sort By:
Pageof 47
Microbiology Spectrum|April 13, 2026
Construction and in vivo characterization of an infectious clone of porcine circovirus type 3 from southwestern ChinaLi-Na Shao, Bao-Ling Liu, Tong Xu, et al.
Molecular Therapy. Nucleic Acids|April 17, 2023
MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA miceTai-Heng Chen, Shih-Hsin Chang, Yu-Fu Wu, et al.
ACS Synthetic Biology|February 11, 2026
Fast and Simplified CRISPR-Cas13d Assay for Sensitive Detection of Porcine DeltacoronavirusYang-Ming Dai, Lei Zhao, Tong Xu, et al.
Antiviral Research|November 28, 2015
Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formationLi Yang, Ya-Juan Wang, Hai-Jun Chen, et al.
Biomaterials|November 12, 2021
MiR-6924-5p-rich exosomes derived from genetically modified Scleraxis-overexpressing PDGFRα(+) BMMSCs as novel nanotherapeutics for treating osteolysis during tendon-bone healing and improving healing strengthWang Feng, Qian Jin, Yang Ming-Yu, et al.
Emerging Microbes & Infections|June 17, 2020
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage siteXi Jin, Kangli Xu, Penglei Jiang, et al.
Ebiomedicine|May 31, 2022
Patient-derived microphysiological model identifies the therapeutic potential of metformin for thoracic aortic aneurysmWenrui Ma, Jingjing Zhang, Shaowen Liu, et al.
Acta Pharmacologica Sinica|February 4, 2014
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidationLi Yang, Li-ping Shi, Hai-jun Chen, et al.
Frontiers in Public Health|August 4, 2022
The Association Between Diabetic Retinopathy and the Prevalence of Age-Related Macular Degeneration-The Kailuan Eye StudyZhang Yongpeng, Wang Yaxing, Zhou Jinqiong, et al.
Acta Pharmacologica Sinica|August 3, 2021
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myelomaYu-Bo Zhou, Yang-Ming Zhang, Hong-Hui Huang, et al.
Pageof 47